Observational studyThe European respiratory journal2026
Pleural fluid neutrophil extracellular traps are associated with disease severity and risk of 1-year mortality in pleural infection: an observational, international, multicohort study (TORPIDS-3).
Observational study in The European respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflux of large numbers of neutrophils is characteristic of pleural infection; however, neutrophil behaviour is understudied. We designed an observational, multicohort study with the aims to discover and validate the association between neutrophil extracellular traps (NETs), disease severity, 1-year survival and the extent of sonographic septations.
methodsWe analysed five independent datasets across three countries. The PILOT cohort (UK, n=215) was used as a discovery cohort for the association of NETs with disease severity, with validation in four independent cohorts across three countries (UK, Greece and Italy, n=100). The PILOT cohort was further analysed to assess the association of NETs with 1-year survival and the development and extent of sonographic septations. A separate cohort (Oxford-Osler, UK, n=30) was used to assess the relationship between NETs and the need for intrapleural enzyme therapy as rescue treatment.
resultsA 10-unit increase in NETs was associated with 13% higher odds of being in a higher RAPID score group (OR 1.13, 95% CI 1.02-1.27; p=0.02), and this association remained robust in the independent validation cohort (OR 1.29, 95% CI 1.11-1.40; p=0.0005). A 10-unit increase in NETs was also associated with a 15% higher risk of 1-year mortality (HR 1.15, 95% CI 1.01-1.32; p=0.04) independent of the RAPID score, and a 17% higher likelihood of sonographic septations (OR 1.17, 95% CI 1.01-1.37; p=0.04). Citrullinated fibrin was associated with septation severity (OR 1.10, 95% CI 1.04-1.16; p=0.00005).
conclusionsPleural fluid NETs are a biomarker of disease severity and 1-year mortality, in pleural infection. Future studies are required to assess the combination of NET-targeting strategies in combination with existing treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.